A phase I study of personalized peptide vaccination for advanced urothelial carcinoma patients who failed treatment with methotrexate, vinblastine, adriamycin and cisplatin

Category Primary study
JournalEuropean Urology, Supplements
Year 2011
This article has no abstract
Epistemonikos ID: df8674cfcfc231f53e3f84c042d4c123e21bdab5
First added on: Feb 04, 2025